Onset of action of antidepressants: results of different analyses

  title={Onset of action of antidepressants: results of different analyses},
  author={C. Thompson},
  journal={Human Psychopharmacology: Clinical and Experimental},
  • C. Thompson
  • Published 2002
  • Psychology, Medicine
  • Human Psychopharmacology: Clinical and Experimental
Because the value of antidepressants is hampered by their delay in onset of action, considerable attention has been focused on developing a drug that acts more rapidly. However, although specific studies are now ongoing, there have been no peer‐reviewed prospective onset of action trials published in the literature to date. Some data are currently available from post‐hoc pooled analyses and numerous methods have been developed for evaluating the onset of action; these include the time to… Expand
Suggested early onset of true action of antidepressant drugs may be artefactual: a heuristic study
Any study seeking to quantify the specific interval for onset of action of antidepressant drugs focusing on only those with well-defined melancholia is argued for. Expand
Assessing activity onset time and efficacy for clinically effective antidepressant and antimanic drugs in animal models based on dominant–submissive relationships
A review of methods used in clinical trials with depression as an indication and approaches taken in animal models of depression and how they could help in assessing drug AOT are focused on. Expand
Mechanisms of antidepressant action: is onset early or late?
The application of more refined statistical approaches, together with better assessments of improvement in the behavioral components of the illness, allows onset to be established in absolute terms. Expand
Contemporary approach to pharmacological and clinical aspects of novel antidepressants
Depression is the most common illness that affects a large number of individuals in all countries. Recent evidence suggest that depressive episodes if left untreated may heighten severity ofExpand
Effects of Antidepressants on Sleep
The aim of this review article was to show that these effects not only depend on the kind of antidepressant drugs but are also related to the dose, the time of drug administration, and the duration of the treatment. Expand
Atypical antipsychotics in the treatment of early-onset schizophrenia
This review summarizes the randomized, double-blind, controlled studies of AAPs in EOS, including clozapine, risperidone, olanzAPine, aripiprazole, paliperid one, quetiapine and ziprasidone. Expand
Affective Disorder and Epilepsy Comorbidity: Implications for Development of Treatments, Preventions and Diagnostic Approaches
  • P. Jobe
  • Medicine
  • Clinical EEG and neuroscience
  • 2004
Significant progress has been made in reducing the adverse effect liability of the antidepressants and the therapeutic effectiveness of carbamazepine may stem from its marked capacity to elevate serotonin concentrations in the extracellular fluid of the brain via mechanisms that differ from those of the membrane reuptake inhibitors. Expand
Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial
This study demonstrated mirtazapine as the first-choice antidepressant for current depressive episodes may reduce benzodiazepine use in patients with MDD. Expand
Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease
Preclinical and clinical studies show the positive role of chronic administration of selective serotonin reuptake inhibitor (SSRI) antidepressants in hindering the progression of the AD and improving patient performance, and antidepressants represent a rational complimentary strategy for the treatment of AD patients with depression comorbidity. Expand
Pharmacokinetics of Fluoxetine in Rhesus Macaques following Multiple Routes of Administration
A daily dose of 10 mg/kg administered orally maintained serum concentrations in the human clinical range over the course of 6 weeks, similar to observations in humans under steady state conditions, norfluoxetine accounted for the greater percentage of active drug in the blood stream. Expand


Time course of improvement under antidepressant treatment: A survival-analytical approach
The most interesting and unexpected finding of the analysis was that the time course of improvement among responders was independent of the treatment modality, and thus identical in all three groups. Expand
Identification of true drug response to antidepressants. Use of pattern analysis.
It is hypothesized and found that substantially more patients receiving active than placebo medication displayed treatment response patterns characterized both by two-week or greater delay in onset of initial improvement and nonfluctuating persistence of improvement once achieved. Expand
Use of pattern analysis to identify true drug response. A replication.
Data from a new sample of 150 nonmelancholic patients support the hypothesis that true drug effect is characterized by a two-week delay in onset and persistence of improvement, once achieved. Expand
Antidepressants: can we determine how quickly they work? Issues from the literature.
: Published reports of antidepressants in clinical trials were reviewed by conducting a literature search focusing on the time period between 1969 and 1994; 240 English-language articles wereExpand
Methodological problems in the estimation of the onset of the antidepressant effect.
A review of the literature published since 1975 was carried out in order to find out if a specific pattern can be observed and points out what problems are most often encountered and illustrate the most common pitfalls. Expand
Mirtazapine compared with paroxetine in major depression.
A potentially faster onset of overall therapeutic efficacy of mirtazapine was suggested by significant differences between treatments after 1 week of therapy that were due to slightly larger improvements of several core symptoms of depression as well as distinct prevention of treatment-emergent worsening of anxiety and physical components of depression. Expand
Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
Mirtazapine was significantly more effective than citalopram after 2 weeks of treatment on the MADRS, HAM-A and CGI Severity of illness and Quality of life scales, and was related to faster improvement of sleep, quality of sleep and improved alertness following awakening, as shown by statistically significant differences on the self-rating LSEQ. Expand
Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.
It was found that mirtazapine was as well tolerated as fluoxetine and significantly more effective after 3 and 4 weeks of therapy. Expand
The Hamilton Depression Scale
It was concluded that the melancholia sub‐scale of the Hamilton Depression Scale can form the basis for further improvements in the field of quantitative rating scales for depressive states. Expand
Comparison between zimeldine and amitriptyline of efficacy and adverse symptoms — a combined analysis of four British clinical trials in depression
ABSTRACT— The similarities and differences in the clinical response and incidence of adverse symptoms between zimeldine and amitriptyline have been evaluated by use of a combined analysis of fourExpand